Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.
Oscar H M LundbergMaria LengquistMartin SpångforsMartin AnnbornDeborah BergmannJanin SchulteHelena LevinOlle MelanderAttila FrigyesiHans FribergPublished in: Critical care (London, England) (2020)
Admission bio-ADM is associated with 30-day mortality and organ failure in sepsis patients as well as in a general ICU population. Bio-ADM may be a morbidity-independent sepsis biomarker.